The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

Mirikizumab is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to the p19 subunit of human interleukin (IL)-23.

Jane Searfoss was inspired to become a child life specialist at Boston Children's Hospital because of her own experience ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

17,000 people answered the IBD UK Patient Survey, and the results reveal patients are facing long waits at every stage of the ...

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

Around 40,000 children in the United States suffer from Crohn's disease. Among those patients, around 1 in 3 will develop perianal fistulas. Perianal fistulas are tunnels that develop near the anus.

Treating Newly-Diagnosed Crohn's Patients With Advanced ... have the skin condition, and children ... Developing a Less Invasive Test for Inflammatory Bowel Disease Sep. 7, 2023 — Millions ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease. A new study published recently in the journal Gut shows children with Crohn's ...

Children diagnosed with inflammatory bowel disease (IBD) face a significantly higher risk for venous thromboembolism (VTE) ...

An elemental diet is a medical protocol that replaces food and drinks with liquid formula for people with serious GI ...